Take a Stand Against Martin Shkreli’s Greed
Remember Martin Shkreli, the hedge fund multi-millionaire whose company raised the price of a life-saving medication, Deraprim, from $13.50 per pill to $750 per pill?
People all over the world very rightly went ballistic.
And the 32-year-old Shkreli — who has bragged about spending $9,000 on a single bottle of wine — begrudgingly said he would scale back the price increase.
But Shkreli reneged on his commitment to lower the cost of this critical drug.